(Q43514238)

English

A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team

scientific article

Statements

A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team (English)
X Sáez-Llorens
R P Nelson
P Emmanuel
A Wiznia
C Mitchell
J A Church
J Sleasman
R Van Dyke
C G Richardson
A Cutrell
W Spreen
S Hetherington
1 January 2001

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit